|
Apr 23
|
Why Summit Therapeutics Inc. (SMMT) Went Up On Wednesday
|
|
Apr 23
|
BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
|
|
Apr 23
|
Why Summit Therapeutics Rocketed Double-Digits Today
|
|
Apr 23
|
Why Is Summit Therapeutics Stock Soaring On Wednesday?
|
|
Apr 23
|
Ivonescimab in Combination with Chemotherapy Achieves Statistically Significant Superiority in PFS vs. Tislelizumab (PD-1 Inhibitor) Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in HARMONi-6 Study Conducted by Akeso in China
|
|
Apr 23
|
This Company's Co-CEOs Just Bought More Shares. Should You?
|
|
Apr 15
|
Why Summit Therapeutics Inc. (SMMT) Skyrocketed On Monday?
|
|
Apr 14
|
Summit Therapeutics (NasdaqGM:SMMT) Welcomes Robert LaCaze As New Chief Commercial Officer
|
|
Apr 14
|
Here's Why Summit Therapeutics Stock Soared 15% on Friday
|
|
Apr 12
|
Why Summit Therapeutics Inc. (SMMT) Soared Last Week?
|
|
Apr 12
|
3 Magnificent Stocks That Could Double or More by 2030
|
|
Apr 12
|
Why Summit Therapeutics Inc. (SMMT) Surged On Friday?
|
|
Apr 6
|
2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a Decade
|
|
Apr 5
|
We Think Summit Therapeutics (NASDAQ:SMMT) Can Easily Afford To Drive Business Growth
|
|
Apr 3
|
Esperion Therapeutics (ESPR) Down 15.8% Since Last Earnings Report: Can It Rebound?
|
|
Apr 3
|
3 Growth Stocks That Have Dwarfed Nvidia's Returns Over the Past 12 Months
|
|
Mar 31
|
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
|
|
Mar 31
|
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
|
|
Mar 30
|
Street Calls of the Week
|
|
Mar 28
|
Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?
|